Rtw Investments, LP Opti Nose, Inc. Transaction History

Rtw Investments, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$6.27 - $11.41 $550,537 - $1 Million	-87,805 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.75 - $8.38 $902 - $1,592	190 Added 0.22%	87,805 $615,000
Q2 2019 Aug 14, 2019	BUY	$6.4 - $10.94 $31,808 - $54,371	4,970 Added 6.01%	87,615 $620,000
Q1 2019 May 15, 2019	BUY	$6.1 - $10.3 $19,391 - $32,743	3,179 Added 4.0%	82,645 $851,000
Q4 2018 Feb 14, 2019	BUY	$5.84 - $11.92 $464,081 - $947,234	79,466 New	79,466 $493,000

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $42.5M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Rtw Investments, LP with notifications on news.